As an independent consultant, David has been providing biotechnology/life science business development services to those in healthcare, agriculture, food and environmental  sectors for over 15 years.  Engagements include: market research, technology assessments and searches for strategic partners.  An avid entrepreneur, he has founded four biotechnology startups, two in healthcare and two in agriculture.  Prior to consulting, David held R&D management positions with several leading healthcare diagnostics firms (Baxter-Travenol, Calbiochem). David provides CEO mentoring services to several organizations in the greater Bay Area. An honors biochemistry graduate of Oxford University, England, David received his PhD in biochemistry from the University of California at Davis.

An experienced management consultant working with small to mid-sized companies, Rob brings  broad experience in finance to VCG.  This includes installing management and accounting systems, developing funding strategies and business plans, and creating economic models.  Prior to his consulting career, Rob served as CFO of a hi-tech manufacturing company, where he also marketed the company's technology to Fortune 100 companies.  Earlier, Rob developed and presented one and five year financial plans to senior management and the Board of Directors of a Fortune 100 corporation.  Rob has participated in over $600 million in institutional financings, and arranged over $22 million in individual investor fundings.  Rob has an MA from Indiana University (Economics) and BA from Knox College (Economics).

Stuart is an entrepreneur with broad ranging P & L experience in start-ups, turnarounds and acquisitions among both Fortune 500 and privately held companies.  Stu started at Proctor & Gamble, and served in senior management positions with Abbott Laboratories, Shaklee, American Hospital Supply/Baxter. After consulting management experience with Coopers & Lybrand he focused his entrepreneurial career on leading turnarounds, start-ups and advising  investors and early stage companies. As President and co-founder of  BioGrowth, a biotechnology company that   successfully isolated and patented  a new therapeutic peptide, he was successful in raising over $5 million in private investment. A Metallurgical Engineering graduate from Purdue University, Stuart received an MBA from Xavier University.